Drug Trial Radar · NCT07759128
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
576
Planned (sponsor's estimate)
Start
Jul 28, 2026
Primary completion
Dec 6, 2028
Study completion Dec 13, 2028
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Aug 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a global, phase 3, randomized, double-blind, parallel-group, 3-arm, placebo-controlled, multicenter study designed to compare the efficacy, safety, and tolerability of fixed doses of SEP-363856 (50 and 75 milligrams per day \[mg/day\]) to placebo in adults at least 18 years of age with generalized anxiety disorder (GAD) over 8 weeks.
Conditions
- Generalized Anxiety Disorder
Interventions
SEP-363856Drug
Oral tablet
PlaceboOther
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline at Week 8 in Hamilton Anxiety Rating Scale (HAM-A) Total ScoreTime frame: Baseline, Week 8
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
The Center for Clinical Trials
Saraland, Alabama · Recruiting
Del Sol Research Management
Tucson, Arizona · Recruiting
Pharmacology Research Institute
Encino, California · Recruiting
California Neuroscience Research Medical Group, Inc
Sherman Oaks, California · Recruiting
Next Level Trials
West Covina, California · Recruiting
Emerson Clinical Research Institute - Washington, DC
Washington D.C., District of Columbia · Recruiting
Sarkis Clinical Trials - Gainesville
Gainesville, Florida · Recruiting
Clinical Neuroscience Solutions, LLC
Jacksonville, Florida · Recruiting
Accel Research Sites - Maitland
Maitland, Florida · Recruiting
CenExel Decatur GA
Decatur, Georgia · Recruiting
AMR-Baber Research Inc
Naperville, Illinois · Recruiting
AMR Conventions Research, Inc
Warrenville, Illinois · Recruiting
Research Works, Inc
New Orleans, Louisiana · Recruiting
Adams Clinical Boston
Boston, Massachusetts · Recruiting
Boston Clinical Trials
Boston, Massachusetts · Recruiting
Vitalix Clinical (Worcester, MA)
Worcester, Massachusetts · Recruiting
Vector Clinical Trials - Las Vegas
Las Vegas, Nevada · Recruiting
Integrative Clinical Trials LLC
Brooklyn, New York · Recruiting
Adams Clinical Harlem
New York, New York · Recruiting
Manhattan Behavioral Medicine PLLC
New York, New York · Recruiting
New Hope Clinical Research
Charlotte, North Carolina · Recruiting
Insight Clinical Trials
Independence, Ohio · Recruiting
Sooner Clinical Research, Inc.
Oklahoma City, Oklahoma · Recruiting
FutureSearch Trials of Dallas
Dallas, Texas · Recruiting
Adams Clinical Dallas
DeSoto, Texas · Recruiting
Earle Research
Friendswood, Texas · Recruiting
Family Psychiatry of the Woodlands
The Woodlands, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.